Clinical Trials Directory

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

A research study of rectal cancer perfusion (how blood flows to the rectum over time). We hope to learn whether perfusion characteristics of rectal masses may be predictive of response to treatment and whether rectal perfusion characteristics can be used to follow response to treatment.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.


Phase: N/A


Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Patients with suspected or biopsy-proven, locally advanced rectal cancer will be eligible for enrollment. - Patients must be 18 years or older. Patients must not be pregnant and, if of child-bearing age, must take precautions not to become pregnant. - No life expectancy restrictions. - ECOG and Karnofsky Performance Status will not be employed. - Patients with renal failure are ineligible for this study (GFR must be > 60) - Ability to understand and willingness to sign a written informed consent document.

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Laura Gable

Footer Links: